You have full access to this article via your institution. The authors suggest that screening for NPM1 mutations will be useful for risk assessment in patients with newly diagnosed AML.

Various forms of blood cancer exist—all of which are grouped together under the term leukemia. One common form of leukemia is ...

Learn about important differences in overall survival and severity of myeloid cell hyperactivation syndrome between strains. These differences are relevant to selecting the most appropriate HIS model ...

The new inhibitors of Abl tyrosine kinase can be distinguished by their nature of binding ... Chronic myeloid leukemia (CML) is a myeloproliferative stem-cell disorder with a tri-phasic course ...

Chronic myeloid leukemia (CML ... can eradicate the hematopoietic stem cell clone may extend the coverage to virtually all patients with bcr-abl. Here we review the 6-year impact of the 'magic ...